Business Wire

BearingPoint acquires disphere tech

Share

Management and technology consultancy BearingPoint announces the 100% acquisition of disphere tech, owner of the cloud platform diContract for the financial services industry. disphere tech will operate as a fully integrated part of BearingPoint and be led by insurance and financial services professionals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005427/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

BearingPoint acquires disphere tech (Photo: Business Wire)

disphere tech is composed of a team of interdisciplinary experts, consultants and developers that provide clients in the financial services industry with comprehensive support for the digital transformation of sales. They design and implement digital sales channels and develop applications for digital process support.

The service portfolio of diContract includes digital onboarding functions, approval of brokerage contracts, video and audio consultations, portfolio transfers, GDPR-compliance features as well as client data and external contract management.

By acquiring disphere tech, BearingPoint strengthens its position both in consulting and in the products area. With diContract, BearingPoint can transform the digital customer onboarding experience within the financial services industry.

Sven Gerhardus, Partner at BearingPoint’s Insurance segment: “In our client projects, it is obvious that communication between insurer, customer, insurance agent, broker and broker pool is a major challenge, especially for traditional insurers. Optimizing and digitalizing these processes with disphere tech’s GDPR-compliant solution is an absolute quick-win for insurance companies. That’s why disphere tech fits excellently in our consulting portfolio. diContract will enhance the digital customer and agent/broker experience in the financial services industry. It’s an all-in-one smart remote selling platform that is simple to use and dramatically reduces process efforts.”

In the first phase, diContract will be made available for clients in Germany, Austria, and Switzerland within the insurance industry.

Patrick Hüttemann, founder of disphere tech: “Our merger with BearingPoint plays in perfectly with our goal of having more of an impact when it comes to supporting our customers in developing sales excellence and digital marketing solutions. BearingPoint’s excellent reputation in the financial services industry and its industry expertise will help us scale our solutions, especially diContract, and allow us to carry out even more ambitious projects.”

Kiumars Hamidian, Managing Partner at BearingPoint: “Integrating IP and assets along with the creation of ventures and innovation are key elements of our strategy 2025. The integration of disphere tech represents a significant step in achieving BearingPoint’s strategic goals. diContract is another highly focused asset that is an excellent addition to our BearingPoint Products portfolio.”

diContract will also be featured in the BearingPoint Store.

Donald Wachs, Head of BearingPoint Products: “Our investment in diContract extends our industry-focused software portfolio and shows that our specific product organization is attractive and enables start-up companies to accelerate their growth story in terms of technology and market reach within BearingPoint. diContract will be added to our BearingPoint Store as the central market place for all our cutting-edge solutions.”

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

For more information, please visit:

Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press
Alexander Bock
Global Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY ® (fremanezumab)24.6.2022 18:54:00 CEST | Press release

Teva Pharmaceuticals Europe B.V. today announces promising interim results from its Pan-European Real World study (PEARL), presented for the first time at the European Academy of Neurology (EAN) Congress in Vienna, Austria. The two-year Pan-European Real World (PEARL) prospective, observational study of AJOVY® (fremanezumab), looks at its effectiveness in patients with chronic migraine or episodic migraine, and is an ongoing study sponsored by Teva Pharmaceuticals Europe BV.1 These findings further offer insight into the treatment of migraine in real-world clinical practice. The interim findings were presented by Faisal Mohammad Amin, Associate Professor of Neurology at the University of Copenhagen, Denmark. Out of the total planned 1100 patients in PEARL, 389 patients are included in the interim analysis presented. These findings show that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more, over the six-month period from the start of treatment. Addit

Brigade-M3 European Acquisition Corp. 2021 Annual Report24.6.2022 16:59:00 CEST | Press release

Brigade-M3 European Acquisition Corp. (the “Company”), a special purpose acquisition company that was incorporated on 21 April 2021 under the laws of the Cayman Islands as an exempted company with limited liability and is listed on Euronext Amsterdam, today published its annual report for the period 21 April 2021 to 31 December 2021. The full report can be downloaded from the Company’s website via the following link: https://www.brigadem3eac.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER This announcement is not for distribution or release, directly or indirectly, and should not be distributed in or sent into, the United States, Australia, Canada, Japan, the Cayman Islands or South Africa or any other jurisdiction in which such distribution or release would be unlawful or would require registration or other measures. This announcement does n

PUMA Kicks Off Its Largest Web3 Collaboration To Date, with 10KTF Shop24.6.2022 16:41:00 CEST | Press release

PUMA has entered New Tokyo, the virtual city 10KTF calls home. The shop is known for its streetwear offerings and is owned by Wagmi-san, a digital artisan whose collections and NFT community recently welcomed the global sports brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220624005314/en/ PUMA Kicks Off Its Largest Web3 Collaboration To Date, with 10KTF Shop PUMA has entered New Tokyo, the virtual city 10KTF calls home. The shop is known for its streetwear offerings and is owned by Wagmi-san, a digital artisan whose collections and NFT community recently welcomed the global sports brand. (Photo: Business Wire) News of the partnership was shared at an event hosted by 10KTF last night in New York. Their event was one of many hosted during the week of NFT.NYC, a conference attended by crypto industry professionals, traders, and other web3 enthusiasts. The official announcement confirms weeks of speculation after PUMA tw

Suzano outlines ESG milestone achievements and commitments at second annual ESG call24.6.2022 16:14:00 CEST | Press release

Suzano, the world’s largest hardwood pulp producer, today held its second annual ESG Call centered around its ambition to be a ‘regenerative company for a regenerative society’. Today’s ESG Call spotlighted measurable progress and ambitions across three core areas of action: climate change, biodiversity and social development. On Climate Change, the ACT initiative of the French Government and CDP scored Suzano ahead of its pulp and paper industry peers in virtually every metric. In 2021, Suzano brought forward its target for removing 40 million tons of carbon dioxide from the atmosphere from 2030 to 2025 which is being achieved through improvements to its industrial processes, such as systematically replacing the use of fossil fuels at its industrial plants with biomass, and through conversion of degraded land. As part of the company’s social commitments, Suzano launched a target in 2020 to lift 200,000 people out of poverty. This is more than pertinent, given that in Brazil, 10% of th

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA ® ▼ (burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)24.6.2022 15:38:00 CEST | Press release

Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that CRYSVITA® (burosumab) be approved for the treatment of FGF23-related hypophosphataemia in Tumour-Induced Osteomalacia (TIO) associated with phosphaturic mesenchymal tumours (PMTs) that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.1 CRYSVITA is also already licensed for use in the rare disease X-Linked Hypophosphataemia (XLH), for children and adolescents between 1 and 17 years of age with radiographic evidence of bone disease, and in adults.2 Also known as oncogenic osteomalacia, TIO is an acquired disorder caused by typically small, slow-growing, benign PMTs.3,4 It is a rare condition with less than 1000 cases reported in the medical literature,4 which mainly affects adults and with a mean onset age of 40 – 45 years.3,5 TIO is associated with p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom